Freda Lewis-Hall - 01 Dec 2023 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Role
Director
Signature
/s/ Freda Lewis-Hall
Issuer symbol
CDT
Transactions as of
01 Dec 2023
Transactions value $
$358,150
Form type
4
Filing time
14 Dec 2023, 17:16:03
Previous filing
26 Sep 2023
Next filing
28 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDT Stock Option (Right to Buy) Award $358K +65K $5.51* 65K 01 Dec 2023 Common Stock 65K $5.51 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Options to purchase common stock, granted under the Company's 2023 Stock Incentive Plan.
F2 The stock options were granted with a ten-year term and vest 33.3% on each of the first three anniversaries of the vesting commencement date, which is September 22, 2023.